Frontiers in Pharmacology (Aug 2022)

Progress on structural modification of Tetrandrine with wide range of pharmacological activities

  • Liuying Mo,
  • Liuying Mo,
  • Liuying Mo,
  • Fan Zhang,
  • Fan Zhang,
  • Fan Zhang,
  • Fan Zhang,
  • Feng Chen,
  • Feng Chen,
  • Feng Chen,
  • Lei Xia,
  • Lei Xia,
  • Lei Xia,
  • Yi Huang,
  • Yuemi Mo,
  • Yuemi Mo,
  • Yuemi Mo,
  • Lingqiu Zhang,
  • Lingqiu Zhang,
  • Lingqiu Zhang,
  • Daquan Huang,
  • Shunli He,
  • Jiagang Deng,
  • Jiagang Deng,
  • Jiagang Deng,
  • Erwei Hao,
  • Erwei Hao,
  • Erwei Hao,
  • Zhengcai Du,
  • Zhengcai Du,
  • Zhengcai Du

DOI
https://doi.org/10.3389/fphar.2022.978600
Journal volume & issue
Vol. 13

Abstract

Read online

Tetrandrine (Tet), derived from the traditional Chinese herb Fangji, is a class of natural alkaloids with the structure of bisbenzylisoquinoline, which has a wide range of physiological activities and significant pharmacfological effects. However, studies and clinical applications have revealed a series of drawbacks such as its poor water solubility, low bioavailability, and the fact that it can be toxic to humans. The results of many researchers have confirmed that chemical structural modifications and nanocarrier delivery can address the limited application of Tet and improve its efficacy. In this paper, we summarize the anti-tumor efficacy and mechanism of action, anti-inflammatory efficacy and mechanism of action, and clinical applications of Tet, and describe the progress of Tet based on chemical structure modification and nanocarrier delivery, aiming to explore more diverse structures to improve the pharmacological activity of Tet and provide ideas to meet clinical needs.

Keywords